Parion Sciences Announces the Presentation of Clinical Data on P-321 Ophthalmic Solution for the treatment of Dry Eye Disease at the Association for Research in Vision and Ophthalmology (ARVO 2016)
May 02, 2016 08:02 ET | Parion Sciences
DURHAM, N.C., May 02, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and  epithelial diseases, announced today the...
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy
February 29, 2016 07:00 ET | GenSight Biologics
PARIS, Feb. 29, 2016 (GLOBE NEWSWIRE) -- GenSight Biologics S.A. (GenSight), a clinical-stage biotechnology company discovering and developing novel gene therapies for neurodegenerative retinal...
eyepoint logo.png
pSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9
January 28, 2016 10:30 ET | EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., Jan. 28, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drugs for treating eye diseases, today announced that...
Applied Genetic Technologies Logo
AGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1 Antitrypsin (AAT) Deficiency
January 20, 2016 07:01 ET | Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and PHILADELPHIA, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical...
Ceva and Zoion Pharma Announce Collaboration to Develop Epithelial Sodium Channel Blockers to Treat Veterinary Ocular Surface Diseases
January 19, 2016 08:00 ET | Parion Sciences
LIBOURNE, France and DURHAM, N.C., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Ceva Santé Animale and Zoion Pharma Inc. announced today that they have entered into a collaboration to develop an epithelial...
Applied Genetic Technologies Logo
AGTC Announces Preclinical Data Evaluating Cone-Specific Promoters for Use in Gene Therapy of Achromatopsia and Other Retinal Diseases
January 07, 2016 07:01 ET | Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
Applied Genetic Technologies Logo
AGTC Leadership to Present at Upcoming Scientific Conferences
January 05, 2016 07:01 ET | Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
Parion Sciences Receives 2015 Life Sciences Award as “Best Late Stage Product Development” Company  
May 22, 2015 09:28 ET | Parion Sciences
DURHAM, N.C., May 22, 2015 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that it was awarded the...
Murad A. Sunalp M.D., B.M., B. Ch.
Photo Release: Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board
January 20, 2015 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is actively recruiting top minds and experts in medicine. The Company is pleased to announce that Murad A. Sunalp M.D.,...
Nextech Systems and MDIntelleSys to Unveil Integrated, Cloud-Based EMR and Practice Management System During the American Academy of Ophthalmology 2014 Annual Meeting
October 18, 2014 11:01 ET | Nextech
TAMPA, FL--(Marketwired - October 18, 2014) - Nextech Systems, the leading provider of specialty-focused healthcare technology solutions for physician practices, announced today the launch of its...